146 related articles for article (PubMed ID: 31312369)
1. VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
Bhandari A; Guan Y; Xia E; Huang Q; Chen Y
Am J Transl Res; 2019; 11(6):3589-3599. PubMed ID: 31312369
[TBL] [Abstract][Full Text] [Related]
2. Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Guan Y; Bhandari A; Zhang X; Wang O
J Cell Mol Med; 2019 Nov; 23(11):7438-7448. PubMed ID: 31496029
[TBL] [Abstract][Full Text] [Related]
3. VASN promotes colorectal cancer progression by activating the YAP/TAZ and AKT signaling pathways via YAP.
Liang W; Zuo J; Liu M; Su Y; Guo B; Hou J; Xing Q; Peng Y; Fang L; Cao Y; Shan J; Sun R; Zhao J; Wang J
FASEB J; 2023 Jan; 37(1):e22688. PubMed ID: 36468780
[TBL] [Abstract][Full Text] [Related]
4. VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ.
Liu H; Kong W; Wen S; Wu J; Yin X; Liu Y
J BUON; 2021; 26(4):1563-1570. PubMed ID: 34565020
[TBL] [Abstract][Full Text] [Related]
5. VASN promotes proliferation of prostate cancer through the YAP/TAZ axis.
Cui FL; Mahmud AN; Xu ZP; Wang ZY; Hu JP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6589-6596. PubMed ID: 32633347
[TBL] [Abstract][Full Text] [Related]
6. LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Xu M; Lin B; Zheng D; Wen J; Hu W; Li C; Zhang X; Zhang X; Qu J
Oncol Lett; 2021 Jun; 21(6):442. PubMed ID: 33868480
[TBL] [Abstract][Full Text] [Related]
7. FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway.
Li M; Gao Z; Ding H; Wang Z; Mu H; Zhang L; Wei J; Ma Z
Evid Based Complement Alternat Med; 2022; 2022():6245647. PubMed ID: 35815268
[TBL] [Abstract][Full Text] [Related]
8. MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
Dong SY; Chen H; Lin LZ; Jin L; Chen DX; Wang OC; Ye ZQ
Cancer Manag Res; 2020; 12():12557-12567. PubMed ID: 33324100
[TBL] [Abstract][Full Text] [Related]
9. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
Jiao X; Ye J; Wang X; Yin X; Zhang G; Cheng X
Med Sci Monit; 2019 Sep; 25():6788-6796. PubMed ID: 31501407
[TBL] [Abstract][Full Text] [Related]
10. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
Jiang HC; Chen XR; Sun HF; Nie YW
Hum Cell; 2020 Jan; 33(1):175-184. PubMed ID: 31782107
[TBL] [Abstract][Full Text] [Related]
12. miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ.
Tang L; Zhou L; Wu S; Shi X; Jiang G; Niu S; Ding D
Onco Targets Ther; 2019; 12():3481-3489. PubMed ID: 31190857
[No Abstract] [Full Text] [Related]
13. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2.
Xia E; Bhandari A; Shen Y; Zhou X; Wang O
Int J Oncol; 2018 Nov; 53(5):1927-1938. PubMed ID: 30106140
[TBL] [Abstract][Full Text] [Related]
14. Cytochalasin H isolated from mangrove-derived endophytic fungus inhibits epithelial-mesenchymal transition and cancer stemness
Xiu Z; Liu J; Wu X; Li X; Li S; Wu X; Lv X; Ye H; Tang X
J Cancer; 2021; 12(4):1169-1178. PubMed ID: 33442415
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
16. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
17. HOXC10 promotes growth and migration of melanoma by regulating Slug to activate the YAP/TAZ signaling pathway.
Miao Y; Zhang W; Liu S; Leng X; Hu C; Sun H
Discov Oncol; 2021 Apr; 12(1):12. PubMed ID: 35201457
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
19. ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma.
Zhao X; Ma W; Li X; Li H; Li J; Li H; He F
J Cancer; 2021; 12(5):1295-1306. PubMed ID: 33531975
[No Abstract] [Full Text] [Related]
20. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
